Demonstrated efficacy |
MOA |
Safety and tolerability profile |
||
|
Explore MAVENCLAD’s efficacy. |
Understand MAVENCLAD’s MOA. |
Learn about MAVENCLAD’s safety |
Reference
- It is expected that most patients with Grade 3 or 4 lymphopenia recover to either normal lymphocyte counts or Grade 1 lymphopenia within 9 months
- To decrease the risk for severe lymphopenia, lymphocyte counts must be determined before, during and after MAVENCLAD treatment
- If lymphocyte counts drop below 500 cells/mm³, active monitoring is recommended until values increase above 500 cells/mm³